Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

A Closer Look at the ACURATE IDE Study

Presentation TCT 2024

A Closer Look at the ACURATE IDE Study

Presenter: NULL

October 30, 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Benefits of MR Elimination & "Why TMVR"

Presentation TCT 2024

Benefits of MR Elimination & "Why TMVR"

Presenter: Michael Reardon

October 29, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.